BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Foglierini M, Marcandalli J, Perez L. HCMV Envelope Glycoprotein Diversity Demystified. Front Microbiol 2019;10:1005. [PMID: 31156572 DOI: 10.3389/fmicb.2019.01005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Pantaleo G, Correia B, Fenwick C, Joo VS, Perez L. Antibodies to combat viral infections: development strategies and progress. Nat Rev Drug Discov 2022. [PMID: 35725925 DOI: 10.1038/s41573-022-00495-3] [Reference Citation Analysis]
2 Ye X, Ku Z, Zhang N, Fu TM, An Z. Recent progress in development of monoclonal antibodies against human cytomegalovirus. Curr Opin Virol 2021;52:166-73. [PMID: 34952264 DOI: 10.1016/j.coviro.2021.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Tang J, Frascaroli G, Zhou X, Knickmann J, Brune W. Cell Fusion and Syncytium Formation in Betaherpesvirus Infection. Viruses 2021;13:1973. [PMID: 34696402 DOI: 10.3390/v13101973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Thomas M, Kropff B, Schneider A, Winkler TH, Görzer I, Sticht H, Britt WJ, Mach M, Reuter N. A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus. J Virol 2021;95:e0065721. [PMID: 34160252 DOI: 10.1128/JVI.00657-21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Akhtar N, Joshi A, Singh J, Kaushik V. Design of a novel and potent multivalent epitope based human cytomegalovirus peptide vaccine: An immunoinformatics approach. Journal of Molecular Liquids 2021;335:116586. [DOI: 10.1016/j.molliq.2021.116586] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
6 Eberhard S, Vietzen H, Görzer I, Jaksch P, Puchhammer-Stöckl E. Analysis and Fine Specificity of the HCMV-Specific Cell-Free and Cell-Associated Antibody-Dependent Cellular Phagocytosis (ADCP) Responses in Lung Transplant Recipients. Int J Mol Sci 2021;22:8206. [PMID: 34360986 DOI: 10.3390/ijms22158206] [Reference Citation Analysis]
7 Wang HY, Valencia SM, Pfeifer SP, Jensen JD, Kowalik TF, Permar SR. Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity. Viruses 2021;13:1106. [PMID: 34207868 DOI: 10.3390/v13061106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vezzani G, Amendola D, Yu D, Chandramouli S, Frigimelica E, Maione D, Merola M. The Human Cytomegalovirus UL116 Glycoprotein Is a Chaperone to Control gH-Based Complexes Levels on Virions. Front Microbiol 2021;12:630121. [PMID: 33889136 DOI: 10.3389/fmicb.2021.630121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zavaglio F, Fiorina L, Suárez NM, Fornara C, De Cicco M, Cirasola D, Davison AJ, Gerna G, Lilleri D. Detection of Genotype-Specific Antibody Responses to Glycoproteins B and H in Primary and Non-Primary Human Cytomegalovirus Infections by Peptide-Based ELISA. Viruses 2021;13:399. [PMID: 33802390 DOI: 10.3390/v13030399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kschonsak M, Rougé L, Arthur CP, Hoangdung H, Patel N, Kim I, Johnson MC, Kraft E, Rohou AL, Gill A, Martinez-Martin N, Payandeh J, Ciferri C. Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry. Cell 2021;184:1232-1244.e16. [PMID: 33626330 DOI: 10.1016/j.cell.2021.01.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
11 Perotti M, Marcandalli J, Demurtas D, Sallusto F, Perez L. Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity. PLoS Pathog 2020;16:e1009169. [PMID: 33370407 DOI: 10.1371/journal.ppat.1009169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Siddiqui S, Hackl S, Ghoddusi H, McIntosh MR, Gomes AC, Ho J, Reeves MB, McLean GR. IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirus. Immunology 2021;162:314-27. [PMID: 33283275 DOI: 10.1111/imm.13286] [Reference Citation Analysis]
13 Ye L, Qian Y, Yu W, Guo G, Wang H, Xue X. Functional Profile of Human Cytomegalovirus Genes and Their Associated Diseases: A Review. Front Microbiol 2020;11:2104. [PMID: 33013768 DOI: 10.3389/fmicb.2020.02104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wang YQ, Zhao XY. Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules. Front Microbiol 2020;11:1511. [PMID: 32765441 DOI: 10.3389/fmicb.2020.01511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
15 Gerna G, Lilleri D. Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development. Vaccines (Basel) 2020;8:E194. [PMID: 32340180 DOI: 10.3390/vaccines8020194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Perotti M, Perez L. Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV. Viruses 2019;12:E35. [PMID: 31905677 DOI: 10.3390/v12010035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
17 Gomes AC, Griffiths PD, Reeves MB. The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ Transplantation. Vaccines (Basel) 2019;7:E67. [PMID: 31319553 DOI: 10.3390/vaccines7030067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]